End Stage COPD Treatment Options at the Lung Institute

The Lung Institute offers innovative cellular therapy for end stage COPD (chronic obstructive pulmonary disease). Our cellular therapy, which uses a patient’s own cells to potentially help reduce inflammation, promote healing and improve quality of life, can be either blood-based or bone marrow-based. The cells used in our procedures are harvested from the patient’s body, separated from other cells in the sample, then reintroduced in a concentrated intravenous infusion that delivers the cells directly to the bloodstream. Because we recognize that no two patients are the same, our knowledgeable staff can help each individual determine which therapy options would best suit his or her specific needs.

Our cellular therapies can be administered during any stage of COPD, though they may be especially beneficial for individuals with end stage chronic obstructive pulmonary disease. People with late stage COPD are often living with a significant reduction in their lung function and quality of life. This can make it particularly challenging to go to work, exercise or complete daily activities around the house, making an effective treatment plan a necessity.

While medications, lifestyle changes and other similar treatments can help alleviate the symptoms of COPD, cellular therapy is unique in that it has the potential to slow the progression of the disease. Patients who have undergone treatment at the Lung Institute have experienced benefits such as:

  • Less pain and shortness of breath
  • Less inflammation in the lungs
  • A reduced need for supplemental oxygen during daily activities

Our cellular therapies are provided on an outpatient basis, allowing patients to return to the comfort of their own homes or hotel accommodations shortly after the infusion process is complete. More than 80 percent of our patients report an improvement in their quality of life after treatment.

To find out if cellular therapy is right for you, call the Lung Institute at (800) 729-3065 to schedule a free consultation. Our team is here to help you find the right options for your end stage COPD treatment and will be happy to answer any questions you might have.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.